President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Patient PortalAdult ClinicPediatricsEye CareMake an AppointmentBillingInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Nathaniel S. Gardiner

Nathaniel Gardiner

Nathaniel S. Gardiner is Senior Vice President and General Counsel of Enanta Pharmaceuticals, Inc., a Watertown, MA biotechnology company focused primarily on discovering drugs for infectious diseases, including hepatitis C.  Until May 2014 he was a partner at the law firm of Edwards Wildman Palmer LLP (formerly Edwards Angell Palmer & Dodge), where he was the co-chair of the Life Sciences Group and served as general counsel to public and private life sciences and technology companies in a wide range of corporate matters.

Nat is a trustee of two private foundations and has previously served as a trustee of the Brookline Community Foundation.

Nat is a graduate of Harvard College and the University of Virginia School of Law.

Page last updated: October 25, 2016